2122 N. Craycroft Road
Suite #112
Tucson, AZ 85712
520-751-0100
irw@immuneclinic.com

Article Search

Latest News | Wellness Center | Functional Medicine | Conditions

Breast Cancer

Immune Recovery Clinic > Articles By Well Known and Acclaimed Medical Professionals > Cancer and Treatments > Breast Cancer
Breast Cancer - Metastasis Are Rare in Pure Ductal Carcinoma
By M.S.W., ZoeMed, Inc.
Posted 03/27/2003; Copyright © 2003 All rights Reserved


Occult metastases are rare in patients with pure ductal carcinoma in situ of the
breast, so sentinel lymph node biopsy may not be required if the tumor is completely
excised and margins are free of invasion.


Dr. Mattia Intra, of the European Institute of Oncology, led the team that evaluated
223 women with pure ductal carcinoma in situ (DCIS), none of which showed any signs
of microinvasion. They all had complete axillary dissection, except for one woman
with evidence of metastasis on sentinel lymph node biopsy; that subject underwent a
mastectomy.

Sentinel lymph node metastases were identified in seven patients, which were
micrometastatic in five. The sentinel lymph node was the only positive node in the
six patients treated with complete axillary dissection. Researchers found no links
with tumor size, grade, histological characteristics, receptor status or presence of
comedo necrosis.

"We believe that any women with DCIS should be informed of this small risk and of
the easy procedure to perform a biopsy of the axillary sentinel lymph node," Dr.
Intra's team reported. But if DCIS is pure, the lesion is completely excised, and
margins of resection are free of invasion, "an sentinel lymph node biopsy could be
avoided."

They also suggested, though, that sentinel lymph node biopsy should be considered
for patients with DCIS who undergo mastectomy if definitive histological features
suggest possible invasion. If the sentinel lymph node is micrometastatic, complete
dissection may not always be necessary.